BioCorRx Inc., a Nevada corporation, entered into a securities purchase agreement on July 29, 2025, with accredited investors. The transaction involved the purchase of 1,000,000 shares of common stock and a warrant to purchase up to an additional 1,000,000 shares, for a total aggregate purchase price of $350,000. The warrant is exercisable at a price of $0.35 per share and is valid for five years from the date of issuance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioCorRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-005396), on August 01, 2025, and is solely responsible for the information contained therein.